Moolec Science Regains Full Nasdaq Compliance, Faces One-Year Monitoring
MLEC has more than doubled off its 52-week low of $3.077 on light trading volume (0.1× avg).
Summary
Moolec Science SA announced it has regained full compliance with all Nasdaq listing requirements, though it will be subject to a one-year monitoring period.
Key Events · Corporate Governance and Compliance · MLEC
-
Regained Full Nasdaq Compliance
Moolec Science SA received notification from the Nasdaq Hearings Panel confirming it has regained compliance with all previously cited Nasdaq Capital Market continued listing requirements, including rules for financial reporting, minimum bid price, and minimum stockholders' equity.
-
One-Year Monitoring Period Imposed
Despite regaining compliance, the company will be subject to a one-year discretionary and mandatory monitoring period by Nasdaq to ensure ongoing adherence to listing rules.
Analysis · MLEC · Manufacturing
Moolec Science SA has successfully regained compliance with all Nasdaq Capital Market listing requirements, including those related to periodic financial reporting, minimum bid price, and minimum stockholders' equity. This is a critical development for the company, as it removes the immediate threat of delisting and allows its shares to continue trading on Nasdaq. However, the Nasdaq Hearings Panel has imposed a one-year discretionary and mandatory monitoring period, indicating continued scrutiny of the company's adherence to listing standards.
At the time of this filing, MLEC was trading at $7.00 on NASDAQ in the Manufacturing sector, with a market capitalization of approximately $5M. The 52-week trading range was $3.08 to $135.60. This filing was assessed with positive market sentiment and an importance score of 8 out of 10.